Skip to content

Artivion AORT Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

Abbott logo
AbbottABT
Edwards Lifesciences logo
Edwards LifesciencesEW
ITG
Integer HoldingsITGR
Boston Scientific logo
Boston ScientificBSX
IAR
Integra LifeSciencesIART
LivaNova logo
LivaNovaLIVN

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%
Free cash flow-$6.8M+66.7%

Valuation

See full
Market cap$1.07B-22.7%
Enterprise value$1.27B-25.5%
P/E91.5×
P/S2.3×-1.2×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's treasury stock, shares (in shares)?
Artivion (AORT) reported treasury stock, shares (in shares) of $1.49M in Q1 2026.
How has Artivion's treasury stock, shares (in shares) changed year-over-year?
Artivion's treasury stock, shares (in shares) decreased by 0.0% year-over-year, from $1.49M to $1.49M.
What is the long-term trend for Artivion's treasury stock, shares (in shares)?
Over 5 years (2020 to 2025), Artivion's treasury stock, shares (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $1.49M to $1.49M.